Absence of amplification role of the protein KLH on antibody response generated by a MAP Staphyloccocus aureus enterotoxin A (SEA) peptide comparing with the corresponding monomeric peptide

Journal of Immunological Methods

Volumn 365, Issue 1-2, 2011, Pages 110-117

  Le Moigne, Vincent ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

Immune response; MAP; Peptide; Vaccine

Indexed keywords

CARRIER PROTEIN; FREUND ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; PEPTIDE; STAPHYLOCOCCUS ENTEROTOXIN A;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FREUND'S ADJUVANT; HEMOCYANIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; STAPHYLOCOCCUS AUREUS;

MUS;

EID: 79551616330     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.12.003     Document Type: Article

References (27)

1. Arnon R., Van Regenmortel M.H. Structural basis of antigenic specificity and design of new vaccines. FASEB J. 1992, 6:3265.
2. Baleux F., Dubois P. Novel version of Multiple Antigenic Peptide allowing incorporation on a cysteine functionalized lysine tree. Int. J. Pept. Protein Res. 1992, 40:7.
3. Bergdoll M.S. Staphylococcal intoxications. Foodborne Infections and Intoxications 1979, 443. Academic Press, Inc, New York. H. Riemann, F.L. Bryan (Eds.).
4. Briand J.P., Barin C., Van Regenmortel M.H.V., Muller S. Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies. J. Immunol. Methods 1992, 156:255.
5. Costa O., Divoux D., Ischenko A., Tron F., Fontaine M. Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG(35-55)peptide in C57BL6/J strain of mice. J. Autoimmun. 2003, 20:51.
6. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslee D., Godard I., Cesbron M.F., Tartar A., Capron A. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J. Immunol. 1992, 149:3636.
7. Dinges M.M., Orwin P.M., Schlievert P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 2000, 13:16.
8. Edelman R., Wasserman S.S., Kublin J.G., Bodison S.A., Nardin E.H., Oliveira G.A., Ansari S., Diggs C.L., Kashala O.L., Schmeckpeper B.J., Hamilton R.G. Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. Vaccine 2003, 21:269.
9. El Ridi R., Montash M., Tallima H. Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Scand. J. Immunol. 2004, 60:392.
10. Farris A.D., Brown L., Reynolds P., Harley J.B., James J.A., Scofield R.H., McCluskey J., Gordon T.P. Induction of autoimmunity by multivalent immunodominant and subdominant T cell determinants of La (SS-B). J. Immunol. 1999, 162:3079.
11. Fitzmaurice C.J., Brown L.E., McInerney T.L., Jackson D.C. The assembly and immunological properties of non-linear synthetic immunogens containing T-cell and B-cell determinants. Vaccine 1996, 14:553.
12. Fitzmaurice C.J., Brown L.E., Kronin V., Jackson D.C. The geometry of synthetic peptide-based immunogens affects the efficiency of T cell stimulation by professional antigen-presenting cells. Int. Immunol. 2000, 12:527.
13. Francis M.J., Hastings G.Z., Brown F., McDermed J., Lu Y.A., Tam J.P. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. Immunology 1991, 73:249.
14. Joshi M.B., Gam A.A., Boykins R.A., Kumar S., Sacci J., Hoffman S.L., Nakhasi H.L., Kenney R.T. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates. Infect. Immun. 2001, 69:4884.
15. Mahale S.D., Pereira J., Natraj U., Iyer K.S. Comparison of antibodies raised against the peptide 10-24 of chicken riboflavin carrier protein (cRCP) by classical and multiple antigen peptide (MAP) approaches. J. Immunol. Methods 1996, 190:215.
16. Marguerite M., Bossus M., Mazingue C., Wolowczuk I., Gras-Masse H., Tartar A., Capron A., Auriault C. Analysis of antigenicity and immunogenicity of five different chemically defined constructs of a peptide. Mol. Immunol. 1992, 29:793.
17. Marussig M., Rénia L., Motard A., Miltgen F., Pétour P., Chauhan V., Corradin G., Mazier D. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection. Int. Immunol. 1997, 9:1817.
18. McLean G.W., Owsianka A.M., Subak-Sharpe J.H., Marsden H.S. Generation of anti-peptide and anti-protein sera. Effect of peptide presentation on immunogenicity. J. Immunol. Methods 1991, 137:149.
19. Misumi S., Nakajima R., Takamune N., Shoji S. A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine. J. Virol. 2001, 75:11,614.
20. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Castro Z.R., Nussenzweig R.S., Schmeckpeper B., Hall B.F., Diggs C., Bodison S., Edelman R. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. J. Infect. Dis. 2000, 182:1486.
21. Nardelli B., Tam J.P. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide. Immunology 1993, 79:355.
22. Olszewska W., Obeid O.E., Steward M.W. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Virology 2000, 272:98.
23. Posnett D.N., McGrath H., Tam J.P. A novel method for producing anti-peptide antibodies. Production of site-specific antibodies to the T cell antigen receptor beta-chain. J. Biol. Chem. 1988, 263:1719.
24. Smith D.J., King W.F., Rivero J., Taubman M.A. Immunological and protective effects of diepitopic subunit dental caries vaccines. Infect. Immun. 2005, 73:2797.
25. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5409.
26. Tam J.P., Zavala F. Multiple antigen peptide. A novel approach to increase detection sensitivity of synthetic peptides in solid-phase immunoassays. J. Immunol. Methods 1989, 124:53.
27. Wang C.Y., Looney D.J., Li M.L., Walfield A.M., Ye J., Hosein B., Tam J.P., Wong-Staal F. Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen. Science 1991, 254:285.